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ABSTRACT
Objective: Simulation  models  are  often  used  to  assess
cost-effectiveness of osteoporosis therapies. Many cost-
effectiveness analyses are interested in a subset of the general
population, such as high-risk patients. As the analyses are
very sensitive to the assumed risk of fracture, it is imperative
that the rates accurately reﬂect the fracture risk in the spec-
iﬁed target population. The objective of this study was to
describe the methodological difﬁculties and present some
possible solutions for calculating the risk of facture in target
populations of interest.
Methods: For binary risk factors, a method for converting
from a relative risk (RR) for people with a risk factor relative
to those without, to an RR in the target population com-
pared with the general population, is described. For contin-
uous risk factors (i.e., bone mineral density [BMD]), data are
often provided as an RR of fracture per SD decrease. A
method for converting from an RR per SD decrease to an RR
in those below a certain BMD threshold, compared with the
general population, is presented.
Results: These results should allow future economic models
to more accurately incorporate existing knowledge of risk
factors by introducing methods to calculate fracture risk esti-
mates in a target population.
Conclusion: It illustrates the importance of considering the
prevalence of risk factors in the general population when cal-
culating RR in a target population.
Keywords: cost-effectiveness analysis; osteoporosis; relative
risk; risk factors.
Introduction
Over the last decade, our knowledge of risk factors for
osteoporotic fractures has greatly increased. Not coin-
cidentally, these years have seen the development of
several new therapies that effectively decrease fracture
risk. With the development of new drug therapies
came the need to assess their economic value to inform
health-care budget allocation decisions. Many cost-
effectiveness analyses to date have utilized disease
simulation models to capture the long-term impact of
osteoporosis therapies, which can have economic and
clinical beneﬁts that extend beyond the time horizon
of most clinical trials [1–6]. These analyses are very
sensitive to the assumed fracture risk in the target pop-
ulation, with cost-effectiveness ratios decreasing when
fracture risk rises.
In many analyses, the target population is a sub-
group of the general population, commonly, high-risk
patients who are at greatest need for treatment. For
example, one may want to consider for treatment oste-
oporosis patients with the following risk factors: very
low bone mineral density (BMD), a previous vertebral
fracture, and a history of falls. Absolute fracture rates
in such high-risk groups are typically not known.
Instead, the fracture rate must be calculated based on
the general population fracture rate and the increased
risk of fracture associated with each risk factor. This is
normally carried out by multiplying the general popu-
lation fracture rate by an overall relative risk (RR) that
represents the risk of fracture in the target population
versus the general population. Nevertheless, the RR
estimates  available  in  the  literature  are  commonly
for patients with a risk factor compared with those
without. Given that cost-effectiveness analyses seek to
estimate the value of treating an at-risk population
compared with doing nothing, the risk comparison of
interest is between the target population and the gen-
eral population. For this application, the published
RRs are an overestimate because some patients within
the general population will also have the risk factor.
In many analyses, the explicit calculation of RR for
the target population is not conducted, or the risks are
overestimated. The purpose of this article is to describe
the challenges in determining RR in a target popula-
tion and present some possible approaches. Speciﬁ-
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cally, we will address two issues: 1) a method for
converting RR estimates for binary risk factors (e.g.,
history of fracture); and 2) a method for converting
RR estimates for continuous risk factors (e.g., BMD).
Methods
Before addressing the speciﬁc issues with binary and
continuous risk factors, it is necessary to understand
how RRs are typically used. In general, several steps
are required if one wants to calculate fracture rates in
the target population based on the presence of risk
factors.
The risk of fracture in the target population is cal-
culated by multiplying the fracture incidence rate for
the general population, by an overall RR estimate that
is indicative of the risk in the deﬁned target population
versus the risk in the general population (e.g., fracture
rate × overall RRtp/gp). The overall RRtp/gp often reﬂects
a range of both binary (i.e., previous vertebral fracture,
history of fracture since age 50 years, maternal history
of hip fracture) and continuous (i.e., BMD, age) risk
factors in the target population.
The overall RR (overall RRtp/gp) is the product of the
RR associated with each individual risk factor in the
target population. For example, the RRtp/gp for a pop-
ulation with a BMD T-score of −2.5 and a previous
vertebral fracture is the RR due to the low BMD T-
score multiplied by the RR of a previous vertebral frac-
ture. It should be noted that multiplying the individual
RR estimates implies that the factors are independent.
Because age, BMD, and other risk factors are closely
related, it is important that one utilize data on RR
from analyses that have simultaneously adjusted for all
of the included risk factors. This was true of the data
included in this analysis.
The methodological challenges discussed in the next
sections arise while estimating the RR associated with
each individual risk factor.
Binary Risk Factors
A number of important binary risk factors for hip frac-
ture in postmenopausal women have been identiﬁed,
including history of postmenopausal fracture, mater-
nal history of hip fracture, and low body weight [4,6–
9]. These risk factors remain important even after
adjustment for each other as well as age and BMD.
Table 1 shows, as examples, two of these risk factors,
history of postmenopausal fracture and maternal his-
tory of fracture, together with their approximate RRs
[4].
In the table, RRw/wo reﬂects the fracture risk in those
people with the risk factor compared with those with-
out. For example, women with a history of postmen-
opausal fracture are at double (RR = 2.0) the risk of a
hip fracture than women who do not have a history of
postmenopausal fracture. Nevertheless, it would be an
overestimate of risk to apply this risk factor when
comparing people with the risk factor with the general
population because the general population will include
both those with the risk factor and those without. The
proportion of the general population with the given
risk factor will vary according to their age, country,
and other factors. Often, economic analyses of oste-
oporosis therapies do not take this into account. Either
they use the RR without adjustment for prevalence in
the general population or they do not explicitly calcu-
late RR rates instead of using illustrative analyses that
assume the target population is at two, three, or four
times the risk of fracture.
The following formula can be used to adjust RRw/wo
to better reﬂect the estimate of interest, which is the
RR of those people with a risk factor compared with
the general population (RRw/gp) [10]. The magnitude of
the correction depends on the prevalence of the risk
factor:
RRw/gp  =  RRw/wo / [(p  ×  RRw/wo)  +  (1  −  p)] (1)
where p is the prevalence of the risk factor in the pop-
ulation being studied.
The last set of columns in Table 1 show that the
RRw/wo is attenuated after the correction for prevalence
and that this attenuation increases with prevalence.
For example, the RRw/wo for history of postmenopausal
fracture is 2.0, comparing those with the risk factor to
those without the risk factor before correction, but
shrinks to 1.74 when the prevalence is 15% and to
1.54 when the prevalence is 30%.
Figure 1 shows the attenuation in RRw/wo as a func-
tion of the RR and prevalence. At the same prevalence,
the absolute magnitude of attenuation is greater as the
RR increases. For a risk factor with 50% prevalence,
for example, if the RRw/wo is 3.0, the RRw/gp is reduced
to about 1.5.
Table 1 Examples of risk factors for hip fracture and the effect of correction for prevalence
Risk factor Type
Relative
risk
(RRw/wo) Unit
Prevalence of
risk factor
Relative risk corrected 
for prevalence (RRw/gp)
Age 65 Age 75 Age 65 Age 75
History of postmenopausal fracture Binary 2.0 Yes/no 15% 30% 1.739 1.538
Maternal history of hip fracture Binary 1.5 Yes/no 10% 14% 1.429 1.402
Femoral neck BMD Continuous 2.3 Per SD See Tables 2 and 3
BMD, bone mineral density.
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Continuous Risk Factors (i.e., BMD)
Often, when considering continuous risk factors, eco-
nomic analyses focus on deﬁning the target population
based on whether they fall above, or below, a thresh-
old level. For example, in osteoporosis, one might be
interested in the risk of fracture among those with
BMD values below a T-score of −2.5, the World Health
Organization threshold deﬁnition of osteoporosis.
Often, analyses in osteoporosis consider risk at the
threshold rather than at or below the threshold, which
is an underestimate of the true fracture risk because
patients below the threshold will be at higher risk than
those at the threshold. Our goal was to develop an
algorithm for assessing the risk of fracture in a popu-
lation below a threshold compared with the overall
risk in the general population. To do this for a target
population compared with the general population,
two issues must be considered: determining the distri-
bution of the target population below the threshold
and adjusting for the proportion of the general popu-
lation below that threshold. A similar methodology
may be used for other continuous risk factors.
The following assumptions were made for BMD as
a continuous risk factor:
1. BMD at any age follows a normal (Gaussian)
distribution with a known mean and an SD [11].
For purposes of illustration, we will work with
femoral neck BMD and use the distributions from
the National Health and Nutrition Examination
Survey III [11]. Table 2 shows the mean and SD
for femoral neck BMD (using a Hologic, QDR
1000) among Caucasian women derived from the
NHANES III study. It also shows the proportion
below  two  T-score  thresholds  (−2.5  and  −1.0)
at  ages  65  and  75 years  using  the  NHANES
III means, SD, and assumption of normal
distribution.
2. The relationship between BMD and fracture risk
follows a logistic risk function. The logistic func-
tion is commonly used to describe the relationship
between risk factors and disease outcomes [12].
We have previously published methods for calcu-
lating parameters for a logistic distribution when
both the RR per SD decrease (BMD to fracture)
and the fracture incidence in the general popula-
tion are known [13]. We will use the general pop-
ulation rates of hip fracture derived from the
National Hospital Discharge Survey [14]. For pur-
poses of illustration, it is assumed that the RR per
SD relating femoral neck BMD to hip fracture risk
is 2.3 [15].
Using the assumptions outlined in numbers 1 and 2,
the risk of hip fracture among those with BMD values
less than a threshold value BMDT can be calculated
using the following relationship:
 
(2)
where
1. Pfa (αa,βa) is the 5-year probability of fracture at
age a at a speciﬁc BMD value (assumed to be a
logistic function), with βa as the logistic slope
relating BMD to fracture risk at age a, and αa as
an intercept term at age a.
2. N(μa,σa) is the Gaussian distribution function with
μa being the mean of BMD at age a and σa being
the SD of BMD at age a.
The functions and relationships outlined in 1) and
2) allow calculation of the general population risk of
fracture at a particular age by integrating with T set at
positive inﬁnity if the two parameters of the normal
distribution and the logistic function are known. Con-
versely, if the fracture risk in the general population at
a particular BMD threshold is known, we can use it
together with three of the four Gaussian/logistic
parameters to solve for the fourth parameter. Speciﬁ-
cally, we can use population age-speciﬁc hip fracture
incidence data [14], the mean and SD of BMD at a spe-
ciﬁc age, and the odds ratio per SD for BMD (a func-
tion of the slope coefﬁcient of the logistic function) to
then solve for the intercept coefﬁcient (αa). Once esti-
mates are available for the four parameters within the
integral, the probability of hip fracture for a popula-
tion with BMD values below any speciﬁc T-score
threshold can be calculated.
For example, we can calculate the risk in those
below the threshold for a set of T-score thresholds
Pfa BMD N dBMDa a
BMD
a a
T
a b m s( ) ( )
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Figure 1 Relative risk (compared with general population [gp] risk) as a
function of prevalence of a binary risk factor.
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Table 2 Distribution of BMD at the femoral neck at ages 65
and 75 years [10]
Age 65 Age 75
Mean BMD (g/cm2) 0.682 0.618
Standard deviation 0.114 0.099
Population below T = −1.0 69% 89%
Population below T = −2.5 18% 34%
BMD, bone mineral density.
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from −1.0 to −3.5. Because the overall fracture risk in
the general population is often known, we will focus
on the ratio of the risk in those below the threshold
compared with the general population.
The means and SDs in Table 2 will be used as the
parameters for the normal distribution in the calcula-
tions. BMD decreases with age, for example, between
ages 65 and 75 years it decreases approximately 10%,
from 0.68 g/cm2 to 0.62 g/cm2. Using the speciﬁc
means and the normal distribution, the proportions
below each T-score threshold are also calculated. For
example, the proportion of the population with BMD
T-score below −2.5 increases from 18% at age 65 years
to 34% at age 75 years.
Table 3 shows the risk of hip fracture in those
below the T-score thresholds at age 65 and 75 years.
At age 65 years, the 5-year risk of hip fracture in the
general population is 1.3% [13]. The risk in those with
BMD T-scores below −2.5 is 3.2%, yielding an RR of
2.46. The risk increases as more extreme thresholds
are chosen. For example, in the 3% of 65-year-old
women with BMD T-scores below −3.5, the risk is
6.0% while among the 69% with BMD T-scores below
−1.0, the risk is only 1.6%. At the same T-score thresh-
olds, the risk increases with age. For example, the risk
in those with femoral neck BMD T-scores below −2.5
increases from 3.2% at age 65 years to 8.1% at age
75 years. Note that if one approximates the risk in
those below the threshold using BMD at the threshold,
the risk is signiﬁcantly underestimated.
Figure 2 shows the RRgp as a function of the prev-
alence of the population with BMD below the thresh-
old for a range of RRs per SD decrease (from 1.4 to
2.6), representing the range seen for commonly used
BMD devices [4]. The RRgp can be obtained for other
RRs per SD decrease by interpolation from this ﬁgure.
Conclusions
Growth in available osteoporosis therapies has led to a
need for tools to assist in the evaluation of new ther-
apies for high-risk populations. Simulation models are
well suited to such evaluations because they allow
cost-effectiveness analyses in populations where pro-
spective data are unavailable and collection of such is
unrealistic [2,3]. Nevertheless, to accurately guide
decision makers in the efﬁcient allocation of resources,
these models must utilize realistic data that reﬂect
fracture risk in the target population. This article
addressed calculation of RR for both dichotomous and
continuous risk factors.
It is commonly referenced that women with a his-
tory of postmenopausal fracture are twice as likely to
have a fracture as women without a similar history.
However, cost-effectiveness analyses seek to compare
treatment of high-risk populations with the general
population, not with patients without risk factors. It is
not commonly considered in analyses that for binary
risk factors, the increased risk in those with the risk
factor compared with average risk in the general pop-
ulation is much less than the increased risk compared
with those without the risk factor. We have quantiﬁed
the extent to which the attenuation depends on the
prevalence of risk factors and have provided a nomo-
gram that can be used to make that adjustment.
Table 3 Risk of hip fracture as a function of BMD T-score
Age
(year)
T-score 
threshold
Fracture risk*
(gp) (%)
Proportion below
threshold (%)
Risk at threshold Risk below threshold 
Risk (%)
RR compared with
gp risk (RRw/gp) Risk (%)
RR compared with
gp risk (RRw/gp)
65 −1.0 1.30 69 0.55 0.423 1.60 1.231
−2.0 1.30 33 1.30 1.000 2.50 1.923
−2.5 1.30 18 1.90 1.462 3.20 2.462
−3.0 1.30 8 3.00 2.308 4.30 3.308
−3.5 1.30 3 4.40 3.385 6.00 4.615
75 −1.0 4.30 89 1.20 0.279 4.60 1.070
−2.0 4.30 55 2.70 0.628 6.30 1.465
−2.5 4.30 34 4.00 0.930 8.10 1.884
−3.0 4.30 17 6.30 1.465 11.00 2.558
−3.5 4.30 6 9.40 2.186 15.60 3.628
*General population (gp) fracture risk over 5 years.
BMD, bone mineral density; RR, relative risk.
Figure 2 Relative risk of fracture (compared with general population
[gp] risk) as a function of prevalence of population with bone mineral den-
sity (BMD) below a threshold.
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Similarly, while the relationship between BMD and
hip fracture risk is often deﬁned as the RR per SD
decrease in BMD, the elevation in risk in the target pop-
ulation with low BMD compared with the general pop-
ulation depends not only on the RR per SD decrease,
but also on the prevalence of low BMD. Similar to a pre-
vious study [16], we have shown that the practice of
assigning risk in a population below a BMD threshold
by assuming BMD exactly at the threshold generally
will underestimate the true RR. We also illustrate the
attenuation due to low BMD in the general population
and have provided a ﬁgure that allows one to calculate
the correct RR compared with the general population
for commonly utilized RR per SD decreases.
When implementing the methods discussed, another
key consideration is that age, BMD, and other risk fac-
tors are all closely related. As such, it is important that
economic models considering these risk factors utilize
data on RR from analyses that have simultaneously
adjusted for all of the included risk factors. This
imposes an important limitation on the variables that
can be included in economic models because simulta-
neous consideration of all risk factors deemed impor-
tant to an analysis is not common. For example, the
Study of Osteoporotic Fractures (SOF) has provided an
analysis of the risk factors for hip fracture which
includes calcaneal BMD together with other risk fac-
tors [6] but has not published studies of these risk fac-
tors together with hip BMD, radial BMD, or calcaneal
ultrasound. The Epidemiology of Osteoporosis Study
also provides information about risk as related to fem-
oral neck BMD in an elderly cohort (age >75 years),
but it considers only a limited set of other risk factors
[7]. This lack of data is even more acute when consid-
ering risk factors for types of fractures other than hip
fractures. These data are especially important when
calculating combined RRs for input into economic
evaluations. The multiplicative approach (i.e., multiply
individual adjusted RRs) assumes that risk factors are
independent or that the RR has been adjusted for con-
founding effects (as is the case with the SOF data). It is
important that those building economic models for
osteoporosis recognize these limitations.
Overall, the methods discussed should allow
researchers to better assess the true risk of fracture in
the target population compared with the general pop-
ulation. This should allow more accurate analyses of
the value of new interventions in preventing fractures.
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